EMA seeks views on draft strategy for network operation to 2025

Article summary

The European Medicines Agency (EMA) has launched a consultation seeking views on a five-year joint strategy for the operation of the network, developed in partnership with the Heads of Medicines Agencies (HMA). The strategy was developed to plan how the network can continue to enable the supply of safe and effective medicines that meet patients’ needs in the face of a number of challenges such as globalisation and the coronavirus (COVID-19) pandemic. It builds on the HMA/EMA strategy to 2020, identifying high-level goals and supporting recommendations in six priority areas, which will guide and shape the work plans of the EMA and national competent authorities in EU Member States for the next five years. The consultation is open until 4 September 2020, and input is welcome from all stakeholders.